abel damien ang
University of Otago, Christchurch
Christchurch, New Zealand
Review Editor
Cancer Molecular Targets and Therapeutics
University of Otago, Christchurch
Christchurch, New Zealand
Review Editor
Cancer Molecular Targets and Therapeutics
University of Florence
Florence, Italy
Review Editor
Cancer Molecular Targets and Therapeutics
Jeju National University
Jeju City, Republic of Korea
Review Editor
Cancer Molecular Targets and Therapeutics
Biomedicine Research Unit, Faculty of Higher Education Iztacala, National Autonomous University of Mexico
Tlalnepantla de Baz, Mexico
Review Editor
Cancer Molecular Targets and Therapeutics
Fox Chase Cancer Center
Philadelphia, United States
Review Editor
Cancer Molecular Targets and Therapeutics
Rush University Medical Center
Chicago, United States
Review Editor
Cancer Molecular Targets and Therapeutics
G. Pascale National Cancer Institute Foundation (IRCCS)
Naples, Italy
Review Editor
Cancer Molecular Targets and Therapeutics
Kırıkkale University
Kırıkkale, Türkiye
Review Editor
Cancer Molecular Targets and Therapeutics
Massachusetts General Hospital, Harvard Medical School
Boston, United States
Review Editor
Cancer Molecular Targets and Therapeutics
Indiana University, Purdue University Indianapolis
Indianapolis, United States
Review Editor
Cancer Molecular Targets and Therapeutics
Texas A&M Health Science Center
Bryan, United States
Review Editor
Cancer Molecular Targets and Therapeutics
Faculty of Dentistry, SĂŁo Paulo State University
Araraquara, Brazil
Review Editor
Cancer Molecular Targets and Therapeutics
University of Mysore
Mysore, India
Review Editor
Cancer Molecular Targets and Therapeutics
School of Medicine, Indiana University Bloomington
Indianapolis, United States
Review Editor
Cancer Molecular Targets and Therapeutics
University of Brescia
Brescia, Italy
Review Editor
Cancer Molecular Targets and Therapeutics
University of California, Los Angeles
Los Angeles, United States
Review Editor
Cancer Molecular Targets and Therapeutics